Tuesday, June 11, 2019 at noon
PA Life Sciences - 650 East Swedesford Road, Wayne, PA 19087
You are developing a product that is showing promise in early nonclinical research. You need to plan for the next stage of development.
- How will FDA regulate your drug, biologic, medical device or combination product?
- What kinds of protections are available for your intellectual property (IP)?
- What patent concerns should you be considering as your product moves through development?
Pharmaceutical, biotechnology and medical device companies must apply for approval from the Food and Drug Administration (FDA) as well as the U.S. Patent and Trademark Office (PTO). Both of these processes can be challenging and time-consuming for small teams, but are necessary to protect and to market your product. Competitive teams need to consider the “effective life” of a patent while moving their product through established regulatory processes as efficiently as possible.
This program is designed for small teams who are heading toward the IND stage of development and want to protect their asset(s) and related intellectual property.
Join Dr. Lisa Jenkins VanLuvanee (Facet Life Sciences) and Jeremy Cubert (Potomac Law Group) as they discuss moving your product through regulatory pathways while being mindful of intellectual property considerations.
Lunch will be provided for all attendees.